Cohesity Named a Storage Technologies "Cool Vendor" by

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
202
Cohesity Named a Storage Technologies "Cool Vendor" by Gartner

SANTA CLARA, CA--(Marketwired - May 18, 2017) - Cohesity, a leading provider of hyperconverged secondary storage technologies, today announced it has been included in the Cool Vendors in Storage Technologies, 2017 1 report by Dave Russell, Arun Chandrasekaran, Julia Palmer, Raj Bala, Alan Dayley, Pushan Rinnen and Garth Landers at Gartner, Inc. The report notes that "it has become painfully evident that storage capacity demands, and expectations for far more rapid provisioning of that storage, have far outpaced the ability of [infrastructure and operations] team's capabilities. Far-more-automated systems are required to restore a sense of balance, that is, storage solutions that offer much greater scale, but also much more automation."

Click to Tweet: .@Cohesity Named a Storage Technology "Cool Vendor" by @Gartner_inc: https://ctt.ec/yftOY+

"We believe Cohesity's inclusion in the 'Cool Vendors in Storage Technologies, 2017' report by Gartner offers further validation of our revolutionary secondary storage approach that empowers customers to scale seamlessly and efficiently across both on-premises and public cloud infrastructures," said Cohesity Vice President of Marketing and Product, Patrick Rogers. "We consolidate and simplify unnecessarily complex secondary storage environments. The enthusiastic response we've received from customers has been a huge driver for our rapidly growing business."

Cohesity, which recently raised $90 million in its Series C funding round , offers a radically efficient way for enterprises to manage surging data volume and complexity. Cohesity DataPlatform replaces fragmented legacy solutions for different secondary storage workloads -- from data protection to analytics -- and converges all secondary data use cases on a single, software-defined platform that spans both on-premises and public cloud environments. Customers leveraging Cohesity's web-scale platform dramatically reduce storage capacity requirements, simplify complex data management processes and extract more value from their data.

A complimentary copy of the Cool Vendors in Storage Technologies, 2017, report is available now on Cohesity's website .

Disclaimer: Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

1 Gartner Cool Vendors in Storage Technologies, 2017" by Dave Russell, Arun Chandrasekaran, Julia Palmer, Raj Bala, Alan Dayley, Pushan Rinnen and Garth Landers, May 12, 2017.

About Cohesity Cohesity makes your data work for you by consolidating secondary storage silos onto a hyperconverged, web-scale data platform that spans both private and public clouds. Enterprise customers begin by radically streamlining their backup and data protection, then converge file and object services, test/dev instances and analytic functions to provide a global data store. Cohesity counts many Global 1000 companies among its rapidly growing customer base. CRN named Cohesity a Top 25 Disrupter and one of the 10 Coolest Hyperconverged Products of 2016. For more information, visit www.cohesity.com and follow @cohesity on Twitter.

Media Contacts BOCA Communications for Cohesity cohesity@bocacommunications.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 294

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 637

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 254

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
"blog__more"> More News Articles